Company profile

INTERACT Technology


Expertise: Sales, Business applications



Bio: INTERACT Technology is a global software company based in Sydney, Australia which identified a systematic gap in the provision of valuable, timely and optimal content and information to healthcare professionals.  myINTERACT was created to fill this gap which assists healthcare professionals in their daily duties and consequently enhances productivity and ultimately improves patient care.

INTERACT Technology continues to dedicate itself to understanding the digital needs of healthcare professionals and the requirements of the companies that engage with them – hospital departments, medical special interest groups, industry associations, event managers and pharmaceutical companies

myINTERACT is now used by many global pharmaceutical companies in over 25 countries and has won awards for innovation and customer engagement.
[Total: 0    Average: 0/5]

News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More


News & Trends - Pharmaceuticals

Pharma News -

Popular high blood pressure drug linked to increased skin cancer risk

Health Industry Hub | August 5, 2020 |

Pharma News: Hydrochlorothiazide, a diuretic, is one of the most prescribed high blood pressure drugs and is used alone or […]

More


News & Trends - Pharmaceuticals

Pharma News - Australian triple therapy for COVID-19 cure and prevention

Australian triple therapy for COVID-19 cure and prevention

Health Industry Hub | August 5, 2020 |

Pharma News: The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody says TGA and FDA approved Ivermectin, which […]

More